Chlamydia trachomatisPersistence in the Female Mouse Genital Tract: Inducible Nitric Oxide Synthase and Infection Outcome
- 1 August 2001
- journal article
- Published by American Society for Microbiology in Infection and Immunity
- Vol. 69 (8) , 5131-7
- https://doi.org/10.1128/iai.69.8.5131-5137.2001
Abstract
It was previously reported that female mice resolve a primary Chlamydia trachomatis urogenital infection independent of inducible nitric oxide synthase (iNOS). We now report that although iNOS-deficient (NOS2(-/-)) mice resolve culture-apparent infection in a fashion similar to that of normal control (NOS2(+/+)) mice, they sustain significantly increased rates of disease, as assessed by hydrosalpinx formation. PCR amplification of ompA followed by Southern blot detection of amplicands revealed the presence of chlamydial DNA in the lower genital tracts of both NOS2(-/-) and NOS2(+/+) mice at > or =120 days postinfection and in upper genital tract tissues at >120 days postinfection. However, only NOS2(-/-) mice shed low numbers of viable chlamydiae from the lower genital tract after immunosuppressive treatment at 120 days postinfection. When cultured primary murine lung fibroblasts were activated in the presence of gamma interferon (IFN-gamma), inhibition of chlamydial growth occurred in both NOS2(+/+) and NOS2(-/-) cells, but the inhibition was reversible after removal of the cytokine in the NOS2(-/-) primary cell culture only. The iNOS-independent inhibition was microbistatic but was independent of 2,3-indoleamine dioxygenase activity. We conclude that chlamydial DNA and antigens persist in mice subsequent to culture-apparent resolution. In addition, IFN-gamma induces in vivo inhibition of chlamydial growth through microbistatic mechanisms in the absence of iNOS activity, but in the presence of iNOS activity, IFN-gamma is microbicidal and effects eradication.Keywords
This publication has 74 references indexed in Scilit:
- Disease Outcome Subsequent to Primary and Secondary Urogenital Infection with Murine or Human Biovars ofChlamydia trachomatisInfection and Immunity, 2000
- Evidence for Long‐Term Cervical Persistence ofChlamydia trachomatisbyomp1GenotypingThe Journal of Infectious Diseases, 2000
- Induction of Tryptophan 2,3-Dioxygenase in the Mouse Endometrium during ImplantationBiochemical and Biophysical Research Communications, 2000
- Chlamydial Heat Shock Protein 60 Localizes in Human Atheroma and Regulates Macrophage Tumor Necrosis Factor-α and Matrix Metalloproteinase ExpressionCirculation, 1998
- REACTIVE ARTHRITISRheumatic Disease Clinics of North America, 1998
- Inhibition of Nitric Oxide Synthase Expression and Activity in Macrophages by 3-Hydroxyanthranilic Acid, a Tryptophan MetaboliteArchives of Biochemistry and Biophysics, 1997
- DoesChlamydia trachomatisMoPn enter a microbiologically-inapparent state during experimental infection of the mouse genital tract?Microbial Pathogenesis, 1997
- Evidence of labile inhibitors in the detection ofChlamydia trachomatis in cervical specimens by polymerase chain reactionEuropean Journal of Clinical Microbiology & Infectious Diseases, 1996
- Nitric oxide production: a mechanism ofChlamydia trachomatisinhibition in interferon-γ-treated RAW264.7 cellsFEMS Immunology & Medical Microbiology, 1996
- Molecular mechanism of T‐cell control of Chlamydia in mice: role of nitric oxide in vivo Immunology, 1996